يعرض 1 - 6 نتائج من 6 نتيجة بحث عن '"sodium-glucose cotransporter 2 inhibitors"', وقت الاستعلام: 0.69s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Heart failure with preserved ejection fraction: everything the clinician needs to know.

    المؤلفون: Campbell, Patricia1 (AUTHOR) patriciam.campbell@southerntrust.hscni.net, Rutten, Frans H2 (AUTHOR), Lee, Matthew MY3 (AUTHOR), Hawkins, Nathaniel M4 (AUTHOR), Petrie, Mark C3 (AUTHOR)

    المصدر: Lancet. Mar2024, Vol. 403 Issue 10431, p1083-1092. 10p.

    مصطلحات موضوعية: VENTRICULAR ejection fraction, SODIUM-glucose cotransporter 2 inhibitors, EPIDEMIOLOGICAL research, DRUG therapy, CLINICAL trials, HEART failure


    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    SGLT2 inhibitors as the bedrock of therapy for heart failure.

    المؤلفون: Tuttle, Katherine R1,2 (AUTHOR) tuttlk@uw.edu, Rangaswami, Janani3 (AUTHOR)

    المصدر: Lancet. Sep2022, Vol. 400 Issue 10354, p711-713. 3p.

    مصطلحات موضوعية: SODIUM-glucose cotransporter 2 inhibitors, HEART failure


    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications.

    المؤلفون: Brown, Emily1,2 (AUTHOR), Heerspink, Hiddo J L3 (AUTHOR), Cuthbertson, Daniel J1,2 (AUTHOR) dan.cuthbertson@liv.ac.uk, Wilding, John P H1,2 (AUTHOR)

    المصدر: Lancet. Jul2021, Vol. 398 Issue 10296, p262-276. 15p.

    مصطلحات موضوعية: GLUCAGON-like peptide-1 agonists, SODIUM-glucose cotransporter 2 inhibitors, CARDIOVASCULAR diseases, MEDULLARY thyroid carcinoma, TYPE 2 diabetes, HEART failure


    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial.

    المؤلفون: Ludvik, Bernhard1 (AUTHOR), Giorgino, Francesco2 (AUTHOR), Jódar, Esteban3 (AUTHOR), Frias, Juan P4 (AUTHOR), Fernández Landó, Laura5 (AUTHOR), Brown, Katelyn5 (AUTHOR), Bray, Ross5 (AUTHOR), Rodríguez, Ángel1,6 (AUTHOR) rodriguez_angel@lilly.com

    المصدر: Lancet. Aug2021, Vol. 398 Issue 10300, p583-598. 16p.

    مصطلحات موضوعية: *RESEARCH, *STATISTICAL sampling, INSULIN aspart, SODIUM-glucose cotransporter 2 inhibitors, TYPE 2 diabetes, INSULIN, METFORMIN, ORAL medication, INSULIN derivatives, RESEARCH methodology, HYPOGLYCEMIC agents, MEDICAL cooperation, EVALUATION research, COMPARATIVE studies, RANDOMIZED controlled trials, SUBCUTANEOUS injections

    الشركة/الكيان: ELI Lilly & Co. LLY


    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial.

    المؤلفون: Frias, Juan P1 (AUTHOR) jfrias@velocityclinical.com, Deenadayalan, Srikanth2 (AUTHOR), Erichsen, Lars2 (AUTHOR), Knop, Filip K3,4,5 (AUTHOR), Lingvay, Ildiko6 (AUTHOR), Macura, Stanislava2 (AUTHOR), Mathieu, Chantal7 (AUTHOR), Pedersen, Sue D8 (AUTHOR), Davies, Melanie9,10 (AUTHOR)

    المصدر: Lancet. 8/26/2023, Vol. 402 Issue 10403, p720-730. 11p.

    مصطلحات موضوعية: TYPE 2 diabetes, SEMAGLUTIDE, SODIUM-glucose cotransporter 2 inhibitors, BLOOD sugar, GLYCEMIC control

    الشركة/الكيان: NOVO Nordisk A/S NVO


    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials.

    المؤلفون: Vaduganathan, Muthiah1 (AUTHOR), Docherty, Kieran F1,2 (AUTHOR), Claggett, Brian L1 (AUTHOR), Jhund, Pardeep S2 (AUTHOR), de Boer, Rudolf A3 (AUTHOR), Hernandez, Adrian F4 (AUTHOR), Inzucchi, Silvio E5 (AUTHOR), Kosiborod, Mikhail N6 (AUTHOR), Lam, Carolyn S P4,7 (AUTHOR), Martinez, Felipe8 (AUTHOR), Shah, Sanjiv J9 (AUTHOR), Desai, Akshay S1 (AUTHOR), McMurray, John J V1,2 (AUTHOR), Solomon, Scott D1 (AUTHOR) ssolomon@bwh.harvard.edu

    المصدر: Lancet. Sep2022, Vol. 400 Issue 10354, p757-767. 11p.

    مصطلحات موضوعية: *HEART failure patients, *ALDOSTERONE antagonists, *HEART failure, *VENTRICULAR ejection fraction, *SODIUM-glucose cotransporter 2 inhibitors, *LEFT heart ventricle, *RESEARCH, *CLINICAL trials, *META-analysis, *LEFT ventricular dysfunction, *RESEARCH methodology, *EVALUATION research, *TYPE 2 diabetes, *COMPARATIVE studies, *HOSPITAL care, *STROKE volume (Cardiac output), *HEART physiology, CARDIOVASCULAR disease related mortality


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث